Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Fixed vs Separate Salmeterol/Fluticasone in Severe COPD
NCT00527826Phase 4Completed
- Sponsor
- GSK
- Start
- Nov 2007
- Primary completion
- Jul 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of salmeterol + fluticasone propionate in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Nov 2007; status: completed.
02
Drugs
salmeterol + fluticasone propionate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00527826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00527826.